Alzheimers Dement
- WANG X, Bakulski KM, Walker E, Mukherjee B, et al
Exposure to lead and incidence of Alzheimer's disease and all-cause dementia in
the United States.
Alzheimers Dement. 2026;22:e71075.
- LIU D, Jiang Z, Kim H, Tukker AM, et al
From correlation to causation: cell-type-specific gene regulatory networks in
Alzheimer's disease.
Alzheimers Dement. 2026;22:e71053.
- JOBSON DD, Hase Y, Walker L, Polvikoski T, et al
High vulnerability of medial prefrontal pyramidal neurons in post-stroke,
vascular, Alzheimer's disease, and aging-related dementias.
Alzheimers Dement. 2026;22:e71151.
- TSIKNIA AA, Terner JA, Tsokolas ZE, Shin DC, et al
Cerebrovascular regulation dynamics and Alzheimer's neuroimaging phenotypes.
Alzheimers Dement. 2026;22:e71146.
- CARY GA, Wiley JC, Carter GW, Levey AI, et al
Beyond the streetlight: a TREAT-AD perspective on where to find new Alzheimer's
targets.
Alzheimers Dement. 2026;22:e71142.
- DUNLOP SR, Matchett BJ, Mannsbart AF, Al-Shaikh FSH, et al
Greater locus coeruleus vulnerability in atypical clinicopathologic forms of
Alzheimer's disease.
Alzheimers Dement. 2026;22:e71140.
- KELEMAN AA, Li M, Wisch JK, Bollinger RM, et al
Falls predict faster progression to Alzheimer's dementia.
Alzheimers Dement. 2026;22:e71177.
- YANG C, Timsina J, Liu M, Budde J, et al
Analyses of plasma multi-omic data across ancestries identify novel pathways
implicated in Alzheimer's disease.
Alzheimers Dement. 2026;22:e71164.
- LI YJ, La JO, Naj A, Martin ER, et al
Leveraging genetic propensity to identify modifiable factors for the age at onset
of Alzheimer's disease.
Alzheimers Dement. 2026;22:e71111.
- CANOVAS R, Fowler CJ, Feizpour A, Dore V, et al
Plasma biomarker progression across the Alzheimer's disease amyloid beta and tau
positron emission tomography trajectories.
Alzheimers Dement. 2026;22:e71145.
- BRUGULAT-SERRAT A, Tsoy E, Sanchez-Benavides G, Mila-Aloma M, et al
Detecting early memory changes in preclinical Alzheimer's disease using TabCAT
favorites test: Data from the European Prevention of Alzheimer's Disease (EPAD)
cohort.
Alzheimers Dement. 2026;22:e71035.
- DE WAAL MWJ, van der Lee SJ, Lunding M, Boonkamp L, et al
Soluble SORL1 in cerebrospinal fluid as a marker for functional impact of rare
SORL1 variants.
Alzheimers Dement. 2026;22:e71042.
- SHISHEGAR R, Doecke JD, Lim YY, Bourgeat P, et al
Harmonizing neuropsychological test data across prospective studies.
Alzheimers Dement. 2026;22:e71186.
- YANG Y, Bhullar R, Conde S
Spatial abilities in aging adults with Down syndrome.
Alzheimers Dement. 2026;22:e71159.
- BOURGEAT P, Fripp J, Lebrat L, Xia Y, et al
AI-enhanced Centiloid quantification of amyloid PET images.
Alzheimers Dement. 2026;22:e71162.
Am J Geriatr Psychiatry
- AW TBH, Leow YJ, Kandiah N
Association of Plasma p-tau181 and Cognition in Nondemented Subjects Without
Abeta(42/40) Positivity.
Am J Geriatr Psychiatry. 2026;34:386-391.
Ann Neurol
- B SZABO A, Curot J, Gerard F, Rulquin F, et al
Refining Detection of Subclinical Epileptiform Activity in Alzheimer's Disease: A
Case-Control Study and Call for a Consensus.
Ann Neurol. 2026 Feb 11. doi: 10.1002/ana.78135.
BMJ
-
New treatments for Alzheimer's disease.
BMJ. 2026;392:s273.
Curr Alzheimer Res
- BANIASADIPOUR B, Bagheri F, Hendudari F, Koopaee S, et al
Molecular and Microstructural MRI of Neuroinflammation in Alzheimer's Disease.
Curr Alzheimer Res. 2026 Feb 4. doi: 10.2174/0115672050420458251115070244.
Exp Neurol
- FARKAS S, Jasper V, Nyers-Marosi K, Petrovai B, et al
Targeting cholinergic cells in a mouse model of Alzheimer's disease: Validating a
quadruple transgenic model.
Exp Neurol. 2026;400:115684.
- WU L, Hou F, Wang Z, Wu M, et al
Mitochondrial calcium uniporter knockdown in hippocampal neurons effectively
attenuates synaptic plasticity impairment and pathology in APP/PS1/tau model of
Alzheimer's disease.
Exp Neurol. 2026 Feb 11:115686. doi: 10.1016/j.expneurol.2026.115686.
J Alzheimers Dis
- ELUGBADEBO O, Farombi T, Arulogun O, Nichols M, et al
Recruiting and retaining persons with suspected Alzheimer's disease and related
dementias for genetic studies in selected African countries: Lived realities of
researchers.
J Alzheimers Dis. 2026 Feb 9:13872877261416066. doi: 10.1177/13872877261416066.
- ZHANG Y, Wang J, Yuan J, Li S, et al
FA-2-b-beta modulates HMGB1/NF-kappaB/NLRP3 signaling to alleviate neuroinflammation in
Alzheimer's disease.
J Alzheimers Dis. 2026 Feb 10:13872877261418300. doi: 10.1177/13872877261418300.
- KUMAR GA, Pravallika P, Thirumalai V, Bukke SPN, et al
Persicaria hydropiper attenuates oxidative stress and reactive oxygen species,
and inhibits amyloid-beta/tau in SH-SY5Y cell lines via multiple pathways of
Alzheimer's disease.
J Alzheimers Dis. 2026 Feb 13:13872877261418555. doi: 10.1177/13872877261418555.
J Neurochem
- BARAL R, van Deventer R, Lyubchenko YL
Amyloid beta-Cholesterol Interplay: Removal of Cholesterol From the Membranes to
Catalyze Aggregation and Amyloid Pathology.
J Neurochem. 2026;170:e70380.
- GIAMBARTOLOMEI GH, Iribarren P, Pasquini LA, Peluffo H, et al
Microglia at the Forefront: New Insights From the Glial Club South Cone Meeting
2025.
J Neurochem. 2026;170:e70384.
J Neurol
- MATIAS-GUIU JA, Ortega-Madueno I, Gil-Moreno MJ, Cardenas MC, et al
Impact of blood p-tau217 testing on diagnosis and diagnostic confidence in
cognitive disorders: a real-world clinical study.
J Neurol. 2026;273:130.
- XIONG D, Liu M, Liu Z, Wang J, et al
Integrating standard and native spaces for radiomics and brain network analysis
in Alzheimer's disease diagnosis and prognosis.
J Neurol. 2026;273:124.
J Neurol Neurosurg Psychiatry
- KATISKO K, Aaltonen M, Aho K, Heikkinen S, et al
Survival and mortality rates in early onset dementia.
J Neurol Neurosurg Psychiatry. 2026;97:256-262.
JAMA Intern Med
- CHIN NA, Erickson CM, Widera E
Importance of Function for Alzheimer Diagnosis and Management-More Than Memory.
JAMA Intern Med. 2026 Feb 9. doi: 10.1001/jamainternmed.2025.7621.
Nat Med
-
Capillary blood sampling for detecting biomarkers of Alzheimer's disease.
Nat Med. 2026 Feb 11. doi: 10.1038/s41591-026-04216.
Neurobiol Dis
- RYSKAMP D, Wu L, Wu J, Kim D, et al
Corrigendum to 'Pridopidine stabilizes mushroom spines in mouse models of
Alzheimer's disease by acting on the sigma-1 receptor' [Neurobiology of Disease
Volume 124 April 2019 Pages 489-504].
Neurobiol Dis. 2026 Feb 13:107311. doi: 10.1016/j.nbd.2026.107311.
Neurochem Res
- CHEN P, Li G, Cheng L, Liu Y, et al
HCG18 is a Potential Pathogenic Factor and Diagnostic Biomarker Alzheimer's
Disease.
Neurochem Res. 2026;51:64.
Neurology
- ZAMMIT AR, Yu L, Poole VN, Kapasi A, et al
Associations of Lifetime Cognitive Enrichment With Incident Alzheimer Disease
Dementia, Cognitive Aging, and Cognitive Resilience.
Neurology. 2026;106:e214677.
Proc Natl Acad Sci U S A
- BOSKOVIC P, Shalita R, Gao W, Vernon H, et al
Engineering chimeric antigen receptor CD4 T cells for Alzheimer's disease.
Proc Natl Acad Sci U S A. 2026;123:e2530977123.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016